Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia
Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia
Recruiting · NCT05139095 · Registry updated 2026-02-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia | Female Urogenital Diseases and Pregnancy Complications, Gestational Trophoblastic Disease, Gestational Trophoblastic Neoplasia, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Pregnancy Complications, Neoplastic, Urogenital Diseases, neoplasm, pregnancy disorder, trophoblastic neoplasm | Recruiting | Phase 2 | 2026-02-05 | NCT05139095 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jiangsu HengRui Medicine Co., Ltd. | 132 |
| Peking Union Medical College Hospital | 417 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peking Union Medical College Hospital | Beijing | China | 112 |